Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).

Clinical trial NCT06213636 · RECRUITING

Trial details

NCT number: NCT06213636
Sponsor: Essen Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, Adult B-Cell Acute Lymphoblastic Leukemia, in Relapse Non-Hodgkin Lymphoma, B-cell Diffuse Large B Cell Lymphoma Central Nervous System Lymphoma Lymphoma, Follicular MCL

Start date: 2024-07-10
Primary completion: 2027-02-10
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.